HIV-1-induced neuronal injury in the developing brain

Area of Science:

• Neuroscience
• Immunology
• Virology

Background:

• HIV-1 infection impacts the central nervous system, causing neuronal damage and dysfunction.
• Infants with HIV-1 infection exhibit impaired brain growth and secondary microcephaly due to vulnerable post-natal brain development.
• HIV-1 infection activates microglia and macrophages, leading to chronic inflammation and release of neurotoxic factors.

Purpose of the Study:

• To investigate the role of prolonged microglial activation in HIV-1-associated neuropathogenesis and impaired brain growth in infants.
• To explore the mechanisms of excitotoxic neuronal injury in the context of HIV-1 infection.
• To identify potential therapeutic targets for HIV-1 neuropathogenesis.

Main Methods:

• The study reviews existing literature on HIV-1 neuropathogenesis, focusing on microglial activation and excitotoxicity.
• It examines the impact of inflammatory products from activated microglia on neuronal injury.
• The role of excitatory amino acid (EAA) receptors and glutamate receptor antagonists is discussed.

Main Results:

• HIV-1 infection leads to chronic inflammation via activated microglia and reactive astrogliosis.
• Microglial inflammatory products like TNF-alpha and PAF act as neuronal toxins.
• Excitotoxicity, potentially mediated by NMDA/AMPA receptors, contributes to oxidative stress, neuronal injury, and apoptosis.

Conclusions:

• Prolonged microglial activation is hypothesized to underlie neuronal injury and impaired brain growth in HIV-1-infected infants.
• Therapeutic strategies should focus on inhibiting microglial immune activation, repairing the blood-brain barrier, and providing neuroprotection.
• Further research into the microglia-neuron interaction in HIV-1 infection is warranted.